APAC GLP-1 Market, Market Segmented, by Drug Type (Exenatide, Liraglutide, Dulaglutide, Lixisenatide), and by Brand (Byetta, Bydureon, Victoza, Trulicity, Lyxumia) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138324
- Pages: 200
-
Format:
Report Overview
The APAC GLP-1 Agonists market size stood at around USD $0.3 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
The GLP-1 drugs are also known as incretin mimetics, a hormone that stimulates insulin secretion in response to meals. GLP-1s are considered an adjunct to diet and exercise, to improve glycemic control in adults with type-2 diabetes mellitus. Patients with type-2 diabetes have diminished insulin release in response to meals, and it is speculated that they may have defects in the release or action of their incretin hormones
Market Drivers
The growth of the market can be attributed to the fact that the type-2 diabetic population is on the rise and isexpected to see further increase in the future, due to the lifestyle choices of individuals.
1. APAC GLP-1 Agonists Overview
A. Market Size
2. APAC GLP-1 Agonists Growth Drivers
A. The growth of the market can be attributed to the fact that the type-2 diabetic population is on the rise
3. APAC GLP-1 Agonists Segmentation
A. By Drug Type
I. Exenatide
II. Liraglutide
III. Dulaglutide
IV. Lixisenatide
B. By Brand
I. Byetta
II. Bydureon
III. Victoza
IV. Trulicity
V. Lyxumia
4. APAC GLP-1 Agonists Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Eli and Lilly, Company overview, Product & Services, Strategies & Financials
B. Novo Nordisk, Company overview, Product & Services, Strategies & Financials
C. AstraZeneca, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
